Fibromyalgia clinical trials is a arthritis related chronic syndrome characterized by specific muscular pain or stiffness, joint or bone pain, tenderness, fatigue and a varying other symptoms. There is no inflammation associated with fibromyalgia and is not life threatening. It is not contagious. By the recent studies it suggests that more females get affected with this syndrome than male (ratio 9:1). It is commonly diagnosed in the people who are between the age of 20 and 50 and is seen in 3% to 6% of the total population. Previously fibromyalgia was considered as an auto immune disorder. The research is going on many of the fibromyalgia clinical trial to find the reasons and cure for this syndrome.

According to the fibromyalgia clinical trial the main symptom of the fibromyalgia is prevalent, diffuse pain, nerve pain, aches around joint. Fibromyalgia is also characterized as a chronic sleep disorder called as alpha wave interrupted sleep pattern. It is a condition in which deep sleep is frequently interrupted by bursts of brain activity. There are many other symptoms of fibromyalgia which includes physical debility, genitourinary symptom, dermatological disorder, headache, symptomatic hypoglycemia, irritable bowel syndrome. It is not necessary that all symptoms will found in all patients. Fibromyalgia may be lead as a result of illness or trauma. It is assumed by the fibromyalgia clinical trial that cold weather, malnutrition, starvation, physical activity may increase the suffering of the patient of fibromyalgia.

While diagnosing the patient of fibromyalgia, the practitioner would take into consideration the patient’s case history. Basically, there is no cure for fibromyalgia, but some treatment options are there. With the experimental treatment, Guaifenesin protocol developed in the fibromyalgia clinical trial by Dr. R. Paul St. Amand there is improvement in their suffering. Because of the successfulness of the treatment it is now used by several doctors in their practices. Even the use of strong drug can not eliminate the pain permanently. New drug including milnacipran, gabapentin, meloxicam and pregabalin shows a significant efficacy on fibromyalgia pain. These drugs are the subject of phase III study in fibromyalgia clinical trial and have got the approval by the FDA (food and drug administration). Along with these medicine some gentle exercise are found to be very beneficial for the patient suffering from fabromyalgia.